Archives of Disease in Childhood - Education and Practice 2008;93:19-25; doi:10.1136/adc.2006.107326
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health
Drugs used in childhood idiopathic or benign intracranial hypertension
Y Y Matthews
Correspondence to:
Y Y Matthews, North East Wales NHS Trust, Wrexham Maelor Hospital; yim-yee.matthews@new-tr.wales.nhs.uk
| The first 150 words of the full text of this article appear below. |
Idiopathic intracranial hypertension (IIH) is a rare condition of increased intracranial pressure (ICP) without any identifiable pathology. Despite intervention, the clinical course of IIH is often prolonged and recurring with potentially serious complications of distressing headache and blindness.1–10 Various therapeutic measures either alone or in combination have been used widely in children with IIH, however, their therapeutic efficacy has not been proven in controlled studies. This article provides a comprehensive review of clinical knowledge in childhood IIH and its various treatment modalities with an emphasis on the drugs used. It also highlights that current management is not evidence based and that well-designed multicentre randomised controlled trials are urgently needed.
 |
TERMINOLOGY
|
|---|
Idiopathic intracranial hypertension was first described in 189711 as "serous meningitis", followed by various names such as otitic hydrocephalus, toxic hydrocephalus, etc, pseudotumour cerebri,12 and the commonly known benign intracranial hypertension.13 Subsequently, IIH was introduced14 and is now a preferred term . . . [Full text of this article]
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health